Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Altamira Therapeutics Ltd’s current trading price is -94.43% away from its 52-week high, while its distance from the 52-week low is 21.19%. The stock’s price range during this period has varied between $0.79 and $17.20. The company, active in the Healthcare sector, saw a trading volume of around 1.04 million for the day, considerably lower average daily volume of 1.27 million observed over the last three months.
Altamira Therapeutics Ltd’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $17.20 on 11/30/23, and the lowest price during the same period was recorded at $0.79 on 08/05/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Altamira Therapeutics Ltd (CYTO) has experienced a quarterly decline of -38.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.14M and boasts a workforce of 12 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4203, with a change in price of -1.3926. Similarly, Altamira Therapeutics Ltd recorded 890,540 in trading volume during the last 100 days, posting a change of -59.26%.
CYTO Stock Stochastic Average
As of today, the raw stochastic average of Altamira Therapeutics Ltd over the past 50 days is 22.62%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 30.44%. Additionally, the Stochastic %K and %D values for the company were 25.90% and 22.49%, respectively, over the past 20 days.
CYTO Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -72.49% this year. Over the last six months, there has been a stronger performance of -48.80%. The price of CYTO leaped by -28.55% during the last 30 days period. For the last 5-days stocks have slided -6.14%.
